| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. | Proc Natl Acad Sci U S A | 2005 | 1.30 |
| 2 | Discovery of a clinical stage multi-kinase inhibitor sodium (E)-2-{2-methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): synthesis, structure-activity relationship, and biological activity. | J Med Chem | 2011 | 1.07 |
| 3 | Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents. | J Med Chem | 2007 | 0.98 |
| 4 | Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridines. | Bioorg Med Chem Lett | 2009 | 0.78 |
| 5 | 2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles. | Bioorg Med Chem Lett | 2009 | 0.75 |